Annual balance sheet for Disc Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 137 | 195 | 360 | 490 | 791 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 140 | 198 | 366 | 494 | 804 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 1.6 | 2.1 | 2.32 | 2.25 |
| Other Long Term Assets | |||||
| Total Assets | 140 | 200 | 368 | 497 | 807 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 14.8 | 22.6 | 21.4 | 23.3 | 36.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.6 | 23.6 | 22.9 | 53.2 | 67.1 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 125 | 177 | 345 | 444 | 740 |
| Total Liabilities & Shareholders' Equity | 140 | 200 | 368 | 497 | 807 |
| Total Common Shares Outstanding |